Filing Details
- Accession Number:
- 0001570562-21-000161
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-17 20:24:30
- Reporting Period:
- 2021-08-13
- Accepted Time:
- 2021-08-17 20:24:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1570562 | Evolus Inc. | EOLS | Pharmaceutical Preparations (2834) | 461385614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1700836 | David Moatazedi | 520 Newport Center Dr. Suite 1200 Newport Beach CA 92660 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-13 | 22,708 | $10.66 | 424,809 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-16 | 47,737 | $11.35 | 377,072 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The shares were sold in multiple trades at prices ranging from $10.65 to $10.725. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The shares were sold in multiple trades at prices ranging from $11.156 to $11.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
